EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Paediatric High Risk B-Lineage ALL: Where Are We in 2026?

Kushedison Yunus, Prattipati Lumen Agarkar, Rakhee Kar, Nalini Pati

Pediatric Hematology Oncology Journal · 2026-11 · 101192

DOI: 10.1016/j.phoj.2026.101192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Hematology Oncology Journal, 2026-11. Verfasst von Kushedison Yunus und 3 weiteren Autor:innen. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

: B lymphoblastic leukemia (B-ALL), the most common childhood malignancy, remains a leading cause of cancer-related mortality in children despite improved cure rates. Recent advances in molecular genetics and measurable residual disease (MRD) monitoring have transformed B-ALL management by enabling identification of distinct molecular subtypes and precise risk stratification. These discoveries have facilitated development of subtype-specific therapeutic approaches, several now advancing through clinical trials. MRD monitoring via multiparameter flow cytometry, real-time quantitative PCR, and next-generation sequencing represents the most powerful independent predictor of relapse risk and long-term survival, guiding treatment intensity modifications. While risk-based protocols have substantially improved paediatric B-ALL survival, managing high-risk molecular subtypes remains challenging. This review synthesizes the clinical significance of molecular genetics and MRD monitoring in prognostication and therapeutic management of paediatric B-ALL.

Zitieren

APA

Yunus, K., Agarkar, P. L., Kar, R., & Pati, N. (2026). Paediatric High Risk B-Lineage ALL: Where Are We in 2026?. Pediatric Hematology Oncology Journal, 101192. https://doi.org/10.1016/j.phoj.2026.101192

Vancouver

Yunus K, Agarkar PL, Kar R, Pati N. Paediatric High Risk B-Lineage ALL: Where Are We in 2026?. Pediatric Hematology Oncology Journal. 2026:101192. doi:10.1016/j.phoj.2026.101192

BibTeX
@article{Yunus2026,
  author = {Yunus, Kushedison and Agarkar, Prattipati Lumen and Kar, Rakhee and Pati, Nalini},
  title = {Paediatric High Risk B-Lineage ALL: Where Are We in 2026?},
  journal = {Pediatric Hematology Oncology Journal},
  year = {2026},
  pages = {101192},
  doi = {10.1016/j.phoj.2026.101192}
}
Kostenlos starten →